CRISPR Therapeutics AG (CRSP) Treasury Shares (2015 - 2026)

CRISPR Therapeutics AG (CRSP) has 10 years of Treasury Shares data on file, last reported at $60000.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 3.23% year-over-year to $60000.0; the trailing twelve-month figure through Mar 2026 stood at $60000.0 (down 3.23% YoY), and the FY2025 full-year result was $60000.0, down 3.23% from the prior year.
• Treasury Shares steadied at $60000.0 in Q1 2026, from $60000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $21.0 million in Q2 2023 to a low of $170316.0 in Q4 2023.
• A 5-year average of $5.7 million and a median of $2.0 million in 2025 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares changed 0.0% in 2022 and declined 3.23% in 2025, its largest moves.
• Tracing CRSP's Treasury Shares over 5 years: stood at $63000.0 in 2022, then fell by 1.59% to $62000.0 in 2023, then changed by 0.0% to $62000.0 in 2024, then retreated by 3.23% to $60000.0 in 2025, then changed by 0.0% to $60000.0 in 2026.
• Business Quant data shows CRSP's Treasury Shares at $60000.0 in Q1 2026, $60000.0 in Q4 2025, and $60000.0 in Q3 2025.